trending Market Intelligence /marketintelligence/en/news-insights/trending/ODa7p8CGuwdiHxwpUCdB4A2 content esgSubNav
In This List

Ipsen to acquire equity stake in Italian consumer health company

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Ipsen to acquire equity stake in Italian consumer health company

French pharmaceutical company Ipsen agreed to acquire an equity stake in Italy-based Akkadeas Pharma, with an option to take control of the company in the future.

Akkadeas, a privately held consumer healthcare company, has a gastrointestinal-focused portfolio including probiotics, medical devices and food supplements.

As part of the deal, Akkadeas will become Ipsen's Italian distributor for Smecta, used to treat acute diarrhea in children and adults.

Financial terms of the strategic transaction were not disclosed.